China Pharma delays third-quarter report, targets Nov. 23 filing
CPHI•China Pharma Holdings delayed its Form 10-Q for the quarter ended September 30, 2026, and is targeting a November 23 filing. Preliminary revenue was approximately $1.15 million, while operating and net losses were approximately $1.88 million and $1.9 million, respectively.
1. Filing delay and results
China Pharma Holdings delayed its Form 10-Q for the quarter ended September 30, 2026, and is targeting filing by November 23. The company said compiling, distributing and reviewing financial information created time constraints that made timely filing impracticable without undue hardship and expense. Preliminary revenue rose to approximately $1.15 million from $760,000 a year earlier, while operating loss widened to approximately $1.88 million from $630,000 and net loss increased to approximately $1.9 million from $650,000.




